Evidence map›Paper›PMID 28450143›Full record

ReviewGeneral and comparative endocrinology2018

Crosstalk between nuclear and G protein-coupled estrogen receptors.

Shannon N Romano, Daniel A Gorelick

Abstract readReview
In one paragraph

Review in General and comparative endocrinology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
5.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 58 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. The relationship between gender and pharmacology.Current research in pharmacology and drug discovery · 2024
    Article
  9. Review
  10. Review
  11. Article
  12. GPER limits adverse changes to CaFrontiers in physiology · 2022
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Shannon N RomanoDepartment of Pharmacology & Toxicology, University of Alabama at Birmingham, USA.
Daniel A GorelickDepartment of Pharmacology & Toxicology, University of Alabama at Birmingham, USA. Electronic address: danielg@uab.edu.
University of Alabama at Birmingham · US

Funding

Training Program in Cell, Molecular, and Developmental BiologyT32GM008111 · NIGMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI YODER, BRADLEY K. · 1985 to 2022
$5.4M
INVESTIGATING ARYL HYDROCARBON RECEPTOR-COFACTOR INTERACTIONS THAT MEDIATE TOXICITYR01ES026337 · NIEHS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Daniel Gorelick · 2016 to 2026
$3.9M
NIEHS NIH HHS R01 ES026337NIGMS NIH HHS T32 GM008111
6 · The paper itself

Abstract

In 2005, two groups independently discovered that the G protein-coupled receptor GPR30 binds estradiol in cultured cells and, in response, initiates intracellular signaling cascades Revankar et al. (2005), Thomas et al. (2005). GPR30 is now referred to as GPER, the G-protein coupled estrogen receptor Prossnitz and Arterburn (2015). While studies in animal models are illuminating GPER function, there is controversy as to whether GPER acts as an autonomous estrogen receptor in vivo, or whether GPER interacts with nuclear estrogen receptor signaling pathways in response to estrogens. Here, we review the evidence that GPER acts as an autonomous estrogen receptor in vivo and discuss experimental approaches to test this hypothesis directly. We propose that the degree to which GPER influences nuclear estrogen receptor signaling likely depends on cell type, developmental stage and pathology.

Indexed as

AnimalsCell NucleusEstradiolEstrogensHumansReceptor Cross-TalkReceptors, EstrogenReceptors, G-Protein-CoupledSignal TransductionEstradiolEstrogensReceptors, EstrogenReceptors, G-Protein-Coupled

Identifiers

PMID28450143
PMCPMC5656538
OpenAlexW2609876712

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.